Back to LLY
AGF MANAGEMENT LTD LLY Position History
Eli Lilly and Company • Healthcare
Quarters held
20
Latest value
$685M
Q3 2026
Peak value
$685M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $240K |
| Q3 2025 | $217K |
| Q3 2025 | $254K |
| Q3 2025 | $87.8M |
| Q4 2025 | $337K |
| Q4 2025 | $90.8M |
| Q4 2025 | $797K |
| Q4 2025 | $306K |
| Q1 2026 | $286K |
| Q1 2026 | $262K |
| Q1 2026 | $462K |
| Q1 2026 | $249.2M |
| Q2 2026 | $411K |
| Q2 2026 | $462K |
| Q2 2026 | $660K |
| Q2 2026 | $665.9M |
| Q3 2026 | $395K |
| Q3 2026 | $450K |
| Q3 2026 | $636K |
| Q3 2026 | $685M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $685M | 592.0K | — | — |
| Q3 2026 | $636K | 550 | — | — |
| Q3 2026 | $450K | 389 | — | — |
| Q3 2026 | $395K | 341 | — | — |
| Q2 2026 | $665.9M | 555.2K | — | — |
| Q2 2026 | $660K | 550 | — | — |
| Q2 2026 | $462K | 385 | — | — |
| Q2 2026 | $411K | 343 | — | — |
| Q1 2026 | $249.2M | 270.9K | — | — |
| Q1 2026 | $462K | 502 | — | — |
| Q1 2026 | $262K | 285 | — | — |
| Q1 2026 | $286K | 311 | — | — |
| Q4 2025 | $306K | 285 | — | — |
| Q4 2025 | $797K | 742 | — | — |
| Q4 2025 | $90.8M | 84.5K | — | — |
| Q4 2025 | $337K | 314 | — | — |
| Q3 2025 | $87.8M | 115.1K | — | — |
| Q3 2025 | $254K | 333 | — | — |
| Q3 2025 | $217K | 285 | — | — |
| Q3 2025 | $240K | 314 | — | — |
Other funds holding LLY
$108.4B
$104.2B
$99.1B
$84.5B
$79.5B
$72.9B
$62.3B
$59.7B